Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
09/2000
09/21/2000WO2000055629A2 Methods of diagnosing and treating breast cancer
09/21/2000WO2000055622A1 Effect of brefeldin a on antigen-presenting cells
09/21/2000WO2000055352A2 50 human secreted proteins
09/21/2000WO2000055351A1 Human colon cancer associated gene sequences and polypeptides
09/21/2000WO2000055350A1 Human cancer associated gene sequences and polypeptides
09/21/2000WO2000055345A2 Therapy of cancer by insect cells containing recombinant baculovirus encoding genes
09/21/2000WO2000055327A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
09/21/2000WO2000055326A1 Chlamydia antigens and corresponding dna fragments and uses thereof
09/21/2000WO2000055320A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides
09/21/2000WO2000055210A1 Method for the reductive amination of polysaccharides
09/21/2000WO2000055201A1 49 human secreted proteins
09/21/2000WO2000055196A1 Protamine fragment compositions and methods of use
09/21/2000WO2000055194A2 Tuberculosis antigens and methods of use therefor
09/21/2000WO2000055192A2 Hemocyanin and nucleic acid sequence coding for the same
09/21/2000WO2000055191A2 Recombinant haemophilus influenzae adhesin proteins
09/21/2000WO2000055183A1 Method for refolding molecules of polypeptides containing ig domains
09/21/2000WO2000055180A2 Human lung cancer associated gene sequences and polypeptides
09/21/2000WO2000055174A1 Human prostate cancer associated gene sequences and polypeptides
09/21/2000WO2000055173A1 Human breast and ovarian cancer associated gene sequences and polypeptides
09/21/2000WO2000055169A1 TCL-1b GENE AND PROTEIN AND RELATED METHODS AND COMPOSITIONS
09/21/2000WO2000054839A2 Dendritic cells transduced with a wild-type self gene elicit potent antitumor immune responses
09/21/2000WO2000054805A1 SURFACE LOCALIZED COLLIGIN/HsP47 IN CARCINOMA CELLS
09/21/2000WO2000054804A1 Use of tgf-beta inhibitors for treating cerebral disorders
09/21/2000WO2000054803A2 Immunostimulatory nucleic acids and antigens
09/21/2000WO2000054802A2 Method of expressing antigens on the surface of antigen presenting cells by photochemical internalization
09/21/2000WO2000054790A1 Immunostimulant bacterial membrane fractions in cancer treatment
09/21/2000WO2000054789A1 Bacterial membrane fractions with adjuvant effect
09/21/2000WO2000054786A1 Methods and compositions for tolerizing hosts for long term survival of tissue transplants
09/21/2000WO2000054783A1 Treatment of asthma
09/21/2000WO2000054749A1 Media in the form of complex dispersions, method for preparing same and uses
09/21/2000WO2000040716A3 Soluble receptor br43x2 and methods of using them for therapy
09/21/2000WO2000039303A3 Modified hiv env polypeptides
09/21/2000WO2000039154A3 Peptides of the at1 receptor and their use for preeclampsia and malign hypertension
09/21/2000WO2000026237A3 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof
09/21/2000WO2000021989A9 Decorin binding proteins dbp a and b and genes encoding them
09/21/2000WO2000021560A9 Flt4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY
09/21/2000WO2000020598A9 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock
09/21/2000WO2000020039A9 Methods and adjuvants for stimulating mucosal immunity
09/21/2000WO2000018783A9 Mammaglobin, a secreted mammary-specific breast cancer protein
09/21/2000WO2000016746A9 Immunogenic liposome compositions
09/21/2000WO2000015792A3 Promotion or inhibition of angiogenesis and cardiovascularization
09/21/2000DE19911329A1 Humantherapeutisch anwendbares Radioimmunkonjugat und Verfahren zu seiner Herstellung Human Therapeutic applicable radioimmunoconjugate and process for its preparation
09/21/2000CA2369319A1 Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
09/21/2000CA2368152A1 Novel methods of diagnosing and treating breast cancer, compositions, and methods of screening for breast cancer modulators
09/21/2000CA2367917A1 Bacterial membrane fractions with adjuvant effect
09/21/2000CA2367906A1 Tcl-1b gene and protein and related methods and compositions
09/21/2000CA2367692A1 Dendritic cells transduced with a wild-type self gene elicit potent antitumor immune responses
09/21/2000CA2367447A1 Treatment of asthma
09/21/2000CA2367357A1 Method
09/21/2000CA2367256A1 Surface localized colligin/hsp47 in carcinoma cells
09/21/2000CA2367211A1 Immunostimulant bacterial membrane fractions in cancer treatment
09/21/2000CA2366195A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides
09/21/2000CA2366174A1 Human colon cancer associated gene sequences and polypeptides
09/21/2000CA2366130A1 Human cancer associated gene sequences and polypeptides
09/21/2000CA2365451A1 Nucleic acid molecule comprising a nucleic acid sequence coding for a hemocyanin
09/21/2000CA2365102A1 Neisseria meningitidis antigenic polypeptides and encoding polynucleotides and uses thereof
09/21/2000CA2364667A1 Recombinant haemophilus influenzae adhesin proteins
09/21/2000CA2364629A1 Human lung cancer associated gene sequences and polypeptides
09/21/2000CA2364590A1 Human prostate cancer associated gene sequences and polypeptides
09/21/2000CA2364568A1 Method for refolding molecules of polypeptides containing ig domains
09/21/2000CA2363022A1 49 human secreted proteins
09/20/2000EP1036798A1 Peptides having anti-cell adhesion activity
09/20/2000EP1036561A1 Buccal, non-polar spray
09/20/2000EP1036188A1 ribG
09/20/2000EP1036180A2 Circovirus sequences related to piglet weight loss disease (pwd)
09/20/2000EP1036091A1 5t4 tumour-associated antigen for use in tumour immunotherapy
09/20/2000EP1035868A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation
09/20/2000EP1035867A1 Transdermal delivery of particulate vaccine compositions
09/20/2000EP1035866A2 Mixed lipopeptide micelles for inducing an immune response and their therapeutic uses
09/20/2000EP1035865A2 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination
09/20/2000EP1035864A2 Methods and compositions for the treatment of psoriasis
09/20/2000EP1035863A1 An over-expressing homologous antigen vaccine and a method of making the same
09/20/2000EP0764030B1 Composition containing autoantibodies for tumor therapy and prophylaxis
09/20/2000EP0742834B1 Method of preparing a viral vector of at least 20kb by intermolecular recombination in a procaryotic cell
09/20/2000EP0623216B1 IMMUNOCHEMICAL DETECTION OF $i(IN VIVO) ADVANCED GLYCOSYLATION ENDPRODUCTS
09/20/2000EP0586549B1 Selecting ligand agonists and antagonists
09/20/2000EP0504327B1 Therapeutic uses of the hypervariable region of monoclonal antibody m195 and constructs thereof
09/20/2000CN1267330A Method for inactivating virus
09/20/2000CN1267224A Treatment of acute lung injury and fibrosis with antagonists of 'alpha' V 'beta' b
09/20/2000CN1266714A Humanized antibody
09/20/2000CN1056647C Production of immunoproximity catalysts
09/20/2000CN1056617C Melanoma-inhibiting protein
09/20/2000CN1056616C Membrane protein polypeptide having supporting pre-B cell growth and gene thereof
09/19/2000US6121427 Major outer membrane protein CD of branhamella
09/19/2000US6121415 An epidermal growth factor receptor polypeptide; for the treatment of nervous system disorders and nervous system damage
09/19/2000US6121414 Protein which can be used to screen for antibiotic activity; for prevention of bacterial infections; bactericides
09/19/2000US6121231 Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuromal and neural injury
09/19/2000US6121230 Administering polypeptide acting as vascular endothelial growth factor antagonist to treat and/or prevent endometriosis
09/19/2000US6121057 Methods of detecting antibodies to α-Fodrin and fragments thereof in diagnosing sjogrens'
09/19/2000US6121044 Potent antigen presenting cell composition
09/19/2000US6121037 Nucleic acid which encodes protein having defined amino acid sequence; for diagnostic reagents against neisseria species infections such as gonorrhea and meningitis; vaccines
09/19/2000US6121035 Amino acid sequences; for screening drugs and producing antibodies
09/19/2000US6121028 MurE
09/19/2000US6121021 Modified human immunodeficiency virus genome devoid of long terminal repeats, with vpr and tat sequences disabled, and linked to constitutive promoter; for stable, long-term production of nonreplicating immunogens for vaccines
09/19/2000US6121020 Secreted complex of polypeptides lacking all or portion of transmembrane domain; for vaccines produced by recombinant production
09/19/2000US6121019 Polynucleotide fragment encoding human polypeptide of defined amino acid sequence; diagnosis, prevention, and treatment of inflammation, disorders associated with cell proliferation and apoptosis; antiinflammatory/antiproliferative agents
09/19/2000US6121018 Polynucleotide which codes for polypeptide of defined amino acid sequence; for therapy and diagnosis of alzheimer's/ parkinson's diseases, multiple sclerosis, amyotrophic lateral sclerosis, septic shock, osteoporosis and other diseases
09/19/2000US6120999 Histidine kinase two-component in Candida albicans
09/19/2000US6120995 Compositions that specifically bind to colorectal cancer cells and methods of using the same
09/19/2000US6120988 Method of detecting hev infection
1 ... 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 ... 1823